Myotonic dystrophy: diagnosis, management and new therapies.

Myotonic dystrophy: diagnosis, management and new therapies.

PURPOSE OF REVIEW: Myotonic dystrophies type 1 and type 2 are progressive multisystem genetic disorders with clinical and genetic features in common. Myotonic dystrophy type 1 is the most prevalent muscular dystrophy in adults and has a wide phenotypic spectrum. The average age of death in myotonic...

Bibliográfalaš dieđut
Váldodahkkit:	Turner, C, Hilton-Jones, D
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2014

Geahča maid

The myotonic dystrophies: diagnosis and management.
Dahkki: Turner, C, et al.
Almmustuhtton: (2010)

Molecular genetics of myotonic dystrophy.
Dahkki: Barnes, P, et al.
Almmustuhtton: (1993)

Myotonic dystrophy--forgotten aspects of an often neglected condition.
Dahkki: Hilton-Jones, D
Almmustuhtton: (1997)

Myotonic dystrophy: practical issues relating to assessment of strength.
Dahkki: Whittaker, R, et al.
Almmustuhtton: (2006)

Clinical and molecular aspects of the myotonic dystrophies: a review.
Dahkki: Machuca-Tzili, L, et al.
Almmustuhtton: (2005)

Three cases of androgen-dependent disease associated with myotonic dystrophy.
Dahkki: Cooper, S, et al.
Almmustuhtton: (2003)

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Dahkki: Talbot, K, et al.
Almmustuhtton: (2003)

Positive effect of modafinil on daytime somnolence on patients with Myotonic Dystrophy
Dahkki: Talbot, K, et al.
Almmustuhtton: (2002)

Incorrect diagnosis of myotonic dystrophy and its potential consequences revealed by subsequent direct genetic analysis.
Dahkki: Barnes, P, et al.
Almmustuhtton: (1994)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1--the patients' perspective.
Dahkki: Hilton-Jones, D, et al.
Almmustuhtton: (2012)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 - The patients' perspective
Dahkki: Hilton-Jones, D, et al.
Almmustuhtton: (2012)

Congenital Myotonic Dystrophy
Dahkki: J Gordon Millichap
Almmustuhtton: (1987-09-01)

MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011
Dahkki: Turner, C, et al.
Almmustuhtton: (2013)

MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011.
Dahkki: Turner, C, et al.
Almmustuhtton: (2013)

A randomised controlled trial of modafinil for treatment of daytime somnolence in myotonic dystrophy
Dahkki: Talbot, K, et al.
Almmustuhtton: (2003)

MRI in Congenital Myotonic Dystrophy
Dahkki: J Gordon Millichap
Almmustuhtton: (1992-10-01)

Cerebral Hypoperfusion in Myotonic Dystrophy
Dahkki: J Gordon Millichap
Almmustuhtton: (1993-10-01)

Myotonic dystrophy type 2
Dahkki: G. E. Rudenskaya, et al.
Almmustuhtton: (2017-02-01)

Cardiac involvement in myotonic dystrophy
Dahkki: Koroush Khalighi, et al.
Almmustuhtton: (2015-02-01)

Ophthalmological findings in myotonic dystrophy
Dahkki: Maddalena De Bernardo, et al.

Desflurane anaesthesia in myotonic dystrophy
Dahkki: Ranju Gandhi, et al.
Almmustuhtton: (2011-01-01)

Myotonic Dystrophy: An Anaesthetic Dilemma
Dahkki: N Gupta, et al.
Almmustuhtton: (2009-01-01)

Prophylactic immunoglobulin therapy for pediatric congenital myotonic dystrophy
Dahkki: Yoji Uejima, et al.
Almmustuhtton: (2024-04-01)

New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC).
Dahkki: Ashizawa, T, et al.
Almmustuhtton: (2000)

Pattern retinal dystrophy in a case of myotonic dystrophy
Dahkki: Chahveer Singh Bindra, et al.
Almmustuhtton: (2023-01-01)

Anesthetic management for a patient with myotonic dystrophy with remimazolam
Dahkki: Yasuhiro Morimoto, et al.
Almmustuhtton: (2021-01-01)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
Dahkki: Josef Finsterer, et al.
Almmustuhtton: (2017-04-01)

Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy.
Dahkki: Zinkernagel, MS, et al.
Almmustuhtton: (2012)

Myotonic Dystrophy: Severity and Maternal Age
Dahkki: J Gordon Millichap
Almmustuhtton: (1992-06-01)

Congenital Myotonic Dystrophy and Pleural Effusion
Dahkki: J Gordon Millichap
Almmustuhtton: (1988-09-01)

Anesthesia for a Patient with Myotonic Dystrophy
Dahkki: Dilek Kalaycı, et al.
Almmustuhtton: (2016-09-01)

Myotonic Dystrophy—A Progeroid Disease?
Dahkki: Peter Meinke, et al.
Almmustuhtton: (2018-07-01)

Molecular genetics of congenital myotonic dystrophy
Dahkki: Stella Lanni, et al.
Almmustuhtton: (2019-12-01)

Myotonic dystrophy: genetics and clinical polymorphism
Dahkki: Ekaterina O. Ivanova, et al.
Almmustuhtton: (2019-03-01)

CONGENITAL MYOTONIC DYSTROPHY – CASE REPORT
Dahkki: David Neubauer, et al.
Almmustuhtton: (2001-07-01)

Core Clinical Phenotypes in Myotonic Dystrophies
Dahkki: Stephan Wenninger, et al.
Almmustuhtton: (2018-05-01)

Alternative isoform regulation in myotonic dystrophy
Dahkki: Wang, Eric T. (Eric Tzy-shi)
Almmustuhtton: (2012)

Congenital Myotonic Dystrophy in the Neonatal Period -
Dahkki: Barbora Červenková
Almmustuhtton: (2023-06-01)

Cutaneous findings in myotonic dystrophyCapsule Summary
Dahkki: Ha Eun Kong, MD, PhD, et al.
Almmustuhtton: (2022-06-01)

Cell membrane integrity in myotonic dystrophy type 1: implications for therapy.
Dahkki: Anchel González-Barriga, et al.
Almmustuhtton: (2015-01-01)